Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-05

FDA Approved: NITYR — Supplemental Application (Cycle Pharmaceuticals Ltd.)

View source ↗

Summary

FDA approved a supplemental application for NITYR (nitisinone) from Cycle Pharmaceuticals Ltd. The approval updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NITYR (Nitisinone)

Snippet

SUPPL AP for NITYR (NITISINONE)